PKS Advisory Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$783K Sell
6,653
-399
-6% -$46.1K 0.18% 113
2025
Q4
$742K Buy
7,052
+1,214
+21% +$114K 0.17% 120
2025
Q3
$49M Buy
5,838
+1,699
+41% +$140K 10.24% 2
2025
Q2
$328K Sell
4,139
-2,387
-37% -$190K 0.08% 184
2025
Q1
$566K Buy
6,526
+2,394
+58% +$224K 0.15% 120
2024
Q4
$411K Buy
+4,132
New +$426K 0.1% 156

Other funds holding MRK

PKS Advisory Services's MRK Position: Q1 2026 in Review

PKS Advisory Services reduced its Merck (MRK) stake by 5.7% in Q1 2026, selling an estimated $46.1K and leaving 6,653 shares worth $783K. The position accounts for 0.18% of the portfolio, ranked #113.

PKS Advisory Services first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $49M in Q3 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PKS Advisory Services held 6,653 shares of Merck worth $783K as of Q1 2026.
  • PKS Advisory Services sold 399 Merck shares in Q1 2026, an estimated $46.1K.
  • Merck made up 0.18% of PKS Advisory Services's portfolio in Q1 2026, its #113 holding.
  • PKS Advisory Services first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • PKS Advisory Services's Merck position peaked at $49M in Q3 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.